In the News

Vita Therapeutics Relocates to University of Maryland BioPark

From its new headquarters and lab space, the biotech company aims to generate state-of-the-art cellular therapeutics for the treatment of debilitating neuromuscular diseases and cancers

Muscular Dystrophy News
Vita Raises $32M to Advance Cell Therapies for LGMD, Other Dystrophies

Science Daily
Lab grown, self-sustainable muscle cells repair muscle injury and disease, mouse study shows